LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Search

Globus Medical Inc (Class A)

Închisă

SectorSănătate

90.59 -0.34

Rezumat

Modificarea prețului

24h

Curent

Minim

89.77

Maxim

90.62

Indicatori cheie

By Trading Economics

Venit

-84M

119M

Vânzări

24M

769M

P/E

Medie Sector

28.508

110.024

EPS

1.18

Marjă de profit

15.469

Angajați

5,300

EBITDA

22M

215M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+17.56% upside

Dividende

By Dow Jones

Următoarele câștiguri

24 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

3.6B

12B

Deschiderea anterioară

90.93

Închiderea anterioară

90.59

Sentimentul știrilor

By Acuity

78%

22%

324 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Globus Medical Inc (Class A) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 feb. 2026, 23:55 UTC

Market Talk

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 feb. 2026, 23:53 UTC

Market Talk

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 feb. 2026, 23:53 UTC

Market Talk

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 feb. 2026, 23:51 UTC

Market Talk

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 feb. 2026, 23:35 UTC

Market Talk

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 feb. 2026, 23:21 UTC

Câștiguri

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 feb. 2026, 23:20 UTC

Câștiguri

Nickel Industries 2025 Operating Profit US$126.4 Million

22 feb. 2026, 23:19 UTC

Câștiguri

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 feb. 2026, 23:19 UTC

Câștiguri

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 feb. 2026, 23:18 UTC

Câștiguri

Nickel Industries Won't Pay a Final Dividend

22 feb. 2026, 23:16 UTC

Câștiguri

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 feb. 2026, 21:35 UTC

Câștiguri

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 feb. 2026, 21:34 UTC

Câștiguri

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 feb. 2026, 21:34 UTC

Câștiguri

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 feb. 2026, 21:33 UTC

Câștiguri

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 feb. 2026, 21:33 UTC

Câștiguri

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 feb. 2026, 21:28 UTC

Câștiguri

Ampol Final Dividend A$0.60/Share

22 feb. 2026, 21:28 UTC

Câștiguri

Ampol FY Revenue A$31.37 Billion, Down 10%

22 feb. 2026, 21:28 UTC

Câștiguri

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 feb. 2026, 21:28 UTC

Câștiguri

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 feb. 2026, 14:31 UTC

Achiziții, Fuziuni, Preluări

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20 feb. 2026, 23:12 UTC

Achiziții, Fuziuni, Preluări

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 feb. 2026, 22:12 UTC

Câștiguri

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 feb. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20 feb. 2026, 21:23 UTC

Câștiguri

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 feb. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 feb. 2026, 21:01 UTC

Achiziții, Fuziuni, Preluări

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 feb. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Comparație

Modificare preț

Globus Medical Inc (Class A) Așteptări

Obiectiv de preț

By TipRanks

17.56% sus

Prognoză pe 12 luni

Medie 106.5 USD  17.56%

Maxim 118 USD

Minim 87 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruGlobus Medical Inc (Class A) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

14 ratings

11

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

72.18 / 73.07Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

324 / 351 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat